A model to predict severe HCV-related disease following liver transplantation

Hepatology

Volumn 38, Issue 1, 2003, Pages 34-41

  Berenguer, Marina ^a   Crippin, Jeffrey ^b   Gish, Robert ^c   Bass, Nathan ^d   Bostrom, Alan ^e   Netto, George ^b   Alonzo, Judy ^d   Garcia Kennedy, Richard ^c   Rayón, Jose Miguel ^a   Wright, Teresa L ^d  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Baylor University   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; MYCOPHENOLIC ACID; PREDNISONE;

ACTUAL PROGRESSION TO SEVERE DISEASE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CUMULATIVE PROBABILITY OF DEVELOPING SEVERE DISEASE; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER DONOR; LIVER FIBROSIS; LIVER TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONBIOLOGICAL MODEL; ORGAN DONOR; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROBABILITY; RECURRENT DISEASE; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; SURVIVAL; VIRUS DETECTION; VIRUS GENE;

EID: 0037785064     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50278     Document Type: Article

References (17)

1. Berenguer M, Lopez-Labrador FX, Wright TL. Hepatitis C and liver transplantation. J Hepatol 2001;35:666-678.
2. Berenguer M, Prieto M, San Juan F, Rayon JM, Martinez F, Carrasco D, Moya A, et al. Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. HEPATOLOGY 2002;36:202-210.
3. Gane E, Portmann B, Naoumov N, Smith HM, Underhill JA, Donaldson PT, Maertens G, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996;334:815-820.
4. Prieto M, Berenguer M, Rayón M, Córdoba J, Argüello L, Carrasco D, García-Herola A, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes. HEPATOLOGY 1999;29:250-256.
5. Berenguer M, Rayón M, Prieto M, Aguilera V, Martinez F, Ortiz V, Carrasco D, et al. Are post-transplantation protocol liver biopsies useful in the long-term? Liver Transplantation 2001;7:790-796.
6. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, Brooks BK, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transpl 2000;6:553-561.
7. Berenguer M, Ferrell L, Watson J, Prieto M, Kim M, Rayon M, Cordoba J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000;32:673-684.
8. Berenguer M, Prieto M, Rayón JM, Mora J, Pastor M, Ortiz V, Carrasco D, et al. Natural history of clinically compensated HCV-related graft cirrhosis following liver transplantation. HEPATOLOGY 2000;32:852-858.
9. Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002;122:889-896.
10. Rosen HR, Shackleton CR, Higa L, Grahek IM, Farmer DA, McDiarmid SV, Holt C, et al. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation. Am J Gastroenterol 1997;92:1453-1457.
11. Berenguer M, Prieto M, Córdoba J, Rayon JM, Catrasco D, Olaso V, San-Juan F, et al. Early development of chronic active hepatitis in recurrent hepatitis C virus infection after liver transplantation: association with treatment of rejection. J Hepatol 1998;28:756-763.
12. Charlton M, Seaberg E. Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Liver Transpl Surg 1999;5(Suppl 1):S107-S114.
13. Charlton M, Seaberg E, Wiesner R, Everhart J, Zetterman R, Lake J, Detre K, et al. Predictors of patient and graft survival following liver transplantation for hepatitis C. HEPATOLOGY 1998;28:823-830.
14. Feray C, Caccamo L, Alexander GJ, Ducot B, Gugenheim J, Casanovas T, Loinaz C, et al. European Collaborative Study on factors influencing the outcome after liver transplantation for hepatitis C. Gastroenterology 1999;117:619-625.
15. Zhou S, Terrault N, Ferrell L, Hahn JA, Lau JYN, Simmonds P, Roberts JP, et al. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia. HEPATOLOGY 1996;24:1041-1046.
16. Gigou M, Roque-Alfonso AM, Falissard B, Penin F, Dussaix E, Feray C. Genetic clustering of hepatitis C virus strains and severity of recurrent hepatitis after liver transplantation. J Virol 2001;75:11292-11297.
17. Brillanti S, Vivarelli M, Abdiueli-Aden A, Aden AA, Camaggi V, D'Errico A, Furlini G, et al. Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation. Liver Transpl 2002;8:884-888.